LIVTECH INC has a total of 37 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HENLIUS BIOTECH CO LTD, PROGASTRINE ET CANCERS S A R L and RECEPTRON INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | EAPO (Eurasian Patent Organization) | 4 | |
#5 | Republic of Korea | 4 | |
#6 | China | 3 | |
#7 | New Zealand | 3 | |
#8 | Brazil | 2 | |
#9 | EPO (European Patent Office) | 2 | |
#10 | Singapore | 2 | |
#11 | United States | 2 | |
#12 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Nakamura Koji | 34 |
#2 | Yanai Hiroyuki | 26 |
#3 | Kanke Toru | 25 |
#4 | Tamura Maki | 20 |
#5 | Okamura Kentaro | 20 |
#6 | Tsurushita Naoya | 18 |
#7 | Kumar Shankar | 18 |
#8 | Tajima Rie | 8 |
#9 | Koji Nakamura | 2 |
#10 | Hiroyuki Yanai | 2 |
Publication | Filing date | Title |
---|---|---|
CN104704119A | Anti-human Dlk-1 antibody having anti-tumor activity in vivo | |
US2013344509A1 | Anti-human TROP-2 antibody having an antitumor activity in vivo | |
WO2011145744A1 | Anti-human trop-2 antibody having antitumor activity in vivo | |
WO2009116670A1 | Anti-human dlk-1 antibody having anti-tumor activity in vivo | |
EP2096122A1 | Anti-human dlk-1 antibody showing anti-tumor activity in vivo |